Kimiko Kanehashi

Title: Kimiko Kanehashi: Innovator in Cancer Treatment

Introduction

Kimiko Kanehashi is a notable inventor based in Ibaraki, Japan. She has made significant contributions to the field of medicine, particularly in cancer treatment. With a total of 3 patents, her work focuses on innovative methods and compounds that aim to improve patient outcomes.

Latest Patents

One of her latest patents is a screening method that provides a medicament for preventing or treating cancer. This invention comprises a tacrine compound or a compound that promotes the binding between the tacrine compound and a protein with a specific amino acid sequence. Another significant patent involves a screening assay using G-protein coupled receptor protein OT7T175. This invention relates to G protein coupled receptor proteins derived from rat cerebellum and human brain, along with methods for screening compounds that alter the binding properties between ligands and these proteins.

Career Highlights

Throughout her career, Kimiko Kanehashi has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. Her work in these organizations has allowed her to contribute to groundbreaking research and development in the field of medicine.

Collaborations

Kimiko has collaborated with esteemed colleagues, including Takuya Watanabe and Yasuko Terao. These partnerships have fostered an environment of innovation and have led to the advancement of her research.

Conclusion

Kimiko Kanehashi's contributions to cancer treatment through her innovative patents and collaborations highlight her role as a significant inventor in the medical field. Her work continues to inspire advancements in healthcare and patient care.